Overexpression of anti-apoptotic proteins BCL2 and BCLX inhibit apoptosis; and are reported to be correlated with the pathogenesis of acute leukaemia (mainly AML), and can induced resistance to chemotherapeutics16,17,65. This evidence concerns the gene BCL2L1 and acute myeloid leukemia.